Search results for "Vaccinations"


 
Results 51 - 60 of about 324 for "Vaccinations".
Sort by: Relevance | Newest | Oldest

Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging

An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021

Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions

Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021

One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound

A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023

Latest on COVID-19 and bamlanivimab, vaccines, long-term effects

Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021

New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’

The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021

Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data

Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021

More clarity on myocarditis with mRNA COVID-19 vaccines

The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023

CDC issues interim guidance on measles infection control and prevention in health care

New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
https://immattersacp.org/weekly/archives/2019/07/30/4.htm
30 Jul 2019

Concomitant influenza infection associated with worse in-hospital outcomes in heart failure patients

Rates of in-hospital mortality, acute respiratory failure with and without mechanical ventilation, and acute kidney injury with and without dialysis were significantly higher in patients admitted with heart failure and influenza infection compared to admissions for heart failure alone.
https://immattersacp.org/weekly/archives/2019/01/08/4.htm
8 Jan 2019

The push toward a COVID-19 vaccine

As America closes in on a vaccine for COVID-19, experts focus on which ones will work best, if at all, how to ramp up production, and how to fairly administer millions of doses.
https://immattersacp.org/archives/2020/11/the-push-toward-a-covid-19-vaccine.htm
1 Nov 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next